Home>Topics>Funds>SPDR S&P Biotech

SPDR S&P Biotech

  1. All
  2. Commentary
  1. SPDR S&P Biotech


    Mon, 8 Dec 2014

    Can I buy this ETF ( XBI ) at Fidelity or Vanguard or are the commissions too high? Schwab or eTrade? Thanks in advance

  2. T/A May 2014 -- SPY "Home On The Range"


    Wed, 30 Apr 2014

    Some plays like XLI are still Bullish. Momentum stocks as represented by QQQ and XBI have broken down and are in a Bearish IT for now. My computer considers her XBI trade management as the “Greatest Escape Since Dunkirk” but she tends to be

  3. April T/A - Sell before May and go away?


    Fri, 28 Mar 2014

    fate of the bull market a little. Again, not enough evidence to pronounce it dead yet though. Speaking of Biotechs This is XBI , and it looks like a heck of a blow off top from where we sit today. I advocated buying if you were a bull yesterday; today

  4. From Barron’s, March 24, 2014 (Part 2)


    Sat, 22 Mar 2014

    bond funds. Pg 35: Biotechs are hot and the related ETFs [ IBB, XBI ] are attracting huge inflows [YTD inflows are already more than those for entire 2013]. The P/E of XBI is 33 excluding negative earnings and -19 [ yes, minus 19 ] after including

  5. Zacks.com


    Sat, 7 Dec 2013

    and two Small Cap ETFs came up also but the big category turned out to be HealthCare. IBB at 12.23%, BBH up 11.71% and XBI up 12.21% to name a few. I counted 12 ETFs up over 6% in the 1 Mon (%). I'm wondering if what I'm hearing in the

  6. From Barron’s, August 26, 2013 (Part 2)


    Sat, 24 Aug 2013

    KRE , insurance KIE , [financials were cutoff at the knees during the financial crisis and have many years to run], biotech XBI and IBB . The ETFs have a strong survivor bias – if something terrible happens with a component, it is replaced by something

Content Partners